<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03159624</url>
  </required_header>
  <id_info>
    <org_study_id>F140612003</org_study_id>
    <nct_id>NCT03159624</nct_id>
  </id_info>
  <brief_title>Nasal Septal Flap for Donor Site Reconstruction</brief_title>
  <official_title>Use of Porcine Small Intestinal Submucosa (SIS) Graft to Aid in Nasal Septal Remucosalization and Tissue Healing in Patients Following Use of Nasoseptal Flap Elevation for Skull Base Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cook Group Incorporated</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the utility of porcine small intestinal submucosa
      (SIS) as a graft material that may aid in the natural healing process of freshly exposed bone
      and cartilage in the nasal cavity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who undergo endoscopic endonasal skull base surgery, and may require nasoseptal flap
      placement as part of skull base reconstruction, will be informed, consented and enrolled for
      participation. If the intraoperative decision is ultimately made for harvest and placement of
      full-length nasoseptal flap by each individual surgeon, patients will then be consecutively,
      sequentially randomized to use of either:

        -  Thin Doyle silastic sheet placement alone over the resulting exposed septum
           cartilage/bone (20 randomly assigned patients)

        -  2x3 cm Biodesign™ SIS perforated mesentery graft surface placement plus overlying Doyle
           silastic sheet placement over the resulting exposed septum cartilage/bone. (20 randomly
           assigned patients)

      When used, Biodesign graft will be soaked in sterile saline out of the packaging, and placed
      as an intact single sheet over the exposed bone nasal septum bone/cartilage (without
      trimming). For uniformity and ease of future analysis, the bottom edge of the graft will be
      placed parallel to, and proximal to, the nasal floor cut edge remnant mucosal surface as
      possible. Except for a thin Doyle silastic sheet to cover the graft site, no additional
      reinforcement (suture/tissue glue) will be placed for those patients in the Biodesign graft
      arm.

      Time Points and Study Parameters:

        -  All enrolled patients will have Doyle silastic sheeting removed only at 2 weeks post-op.

        -  All patients will receive 250cc normal saline topical nasal rinses starting at 14 days
           until 120 days post-op.

        -  No topical irrigation additives (budesonide/mupirocin) will be administered over 12
           weeks.

      All patients will be assessed at 2 weeks, 6 weeks and 12 weeks following randomization and
      entry into this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 13, 2014</start_date>
  <completion_date type="Actual">March 21, 2016</completion_date>
  <primary_completion_date type="Actual">March 21, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean change in post-operative remucosalization, locoregional crusting, and edema at the donor site</measure>
    <time_frame>12 weeks</time_frame>
    <description>Mean change as measured by Visual Analogue Scale (VAS) scores from 3 independent reviewers from endoscopy videos collected at 2, 6, and 12 weeks.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Nasal Septum Perforation</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2x3 cm Biodesign™ SIS graft placement + overlying Doyle silastic sheet placement over the resulting exposed septum cartilage/bone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thin Doyle silastic sheet placement alone over the resulting exposed septum cartilage/bone</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biodesign™ SIS graft</intervention_name>
    <description>2x3 cm Biodesign™ SIS perforated mesentery graft</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Doyle silastic sheet</intervention_name>
    <description>Doyle silastic sheet</description>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective transnasal endoscopic skull base surgery where closure with a large
             nasoseptal flap (NSF) is anticipated (exposure of &gt;75% of the ipsilateral nasal septum
             bone/cartilage)

          -  Patients without nutritional compromise or otherwise debilitated

          -  Patients who are able to consent for themselves

        Exclusion Criteria:

          -  Bilateral nasoseptal flap (NSF) placement in the same operative setting

          -  Patients without significant bone/cartilage exposure to incorporate an intact 2x3 cm
             graft

          -  Patients requiring 24 hour supplemental oxygen via nasal cannula

          -  Patients who cannot consent for themselves
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brad Woodworth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2017</study_first_submitted>
  <study_first_submitted_qc>May 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2017</study_first_posted>
  <last_update_submitted>May 17, 2017</last_update_submitted>
  <last_update_submitted_qc>May 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Brad Woodworth, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>nasoseptal flap</keyword>
  <keyword>tissue repair</keyword>
  <keyword>wound healing</keyword>
  <keyword>remucosalization</keyword>
  <keyword>upper airway</keyword>
  <keyword>granulation tissue</keyword>
  <keyword>tissue graft</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nasal Septal Perforation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

